|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2970447 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14711899.6 |
| Date of filing the European patent application | 2014-03-05 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-16 |
| (46) | Date of publication of the claims translation | 2018-07-25 |
| (86) | Number | PCT/US2014/020605 |
| Date | 2014-03-05 |
| (87) | Number | WO 2014/149733 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361792800 P | 2013-03-15 | US |
| (72) |
BEIDLER, Catherine Brautigam, US
KIKLY, Kristine Kay, US
STRIFLER, Beth Ann, US
WITCHER, Derrick Ryan, US
BOYLES, Jeffrey Streetman, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Antikūnai PAN-ELR+ CXC chemokinams |
| PAN-ELR+ CXC CHEMOKINE ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 13 | 289.00 EUR |
| 2027-03-05 |